JCGG Symposia

The 10th Symposium of Japanese Consortium for Glycobiology and Glycotechnology

Glycan-based therapeutics and beyond
Infection, inflammation, immunity and Glycoscience
December 4-5, 2014 Tokyo Medical and Dental University (Tokyo)
program December 4 (Thursday), 2014
9:30-9:40 Greetings from JCGG President
Naoyuki Taniguchi (RIKEN)
9:40-9:50 Opening Address of organizer
Takeshi Tsubata (Tokyo Medical and Dental University)
Chairperson :
Tatusro Irimura
(St. Luke's International Hospital)
09:50-11:05 ◊  Session 1

Mechanism for immune activation induced by synthetic sialosides
Takeshi Tsubata (Tokyo Medical and Dental University)

Design and synthesis of the ligands aswell as inhibitors to elucidate the bilogical functions of animal lectins
Hideharu Ishida (Gifu University)

Affinity and specificity on lectin-sugar interaction
Yoshiki Yamaguchi (RIKEN)

Involvement of glycosphingolipid metabolism in maintenance and breakdown of homeodinamic state
Jin-ichi Inokuchi (Tohoku Pharmaceutical University)
11:05-11:30  Break
Chairperson :
Takeshi Tsubata (Tokyo Medical and Dental University)
11:30-12:15 Special Lecture I
Adjuvant data base project: new mode of action and biomarker
Ken J, Ishii (NIBIO)
12:15-13:30  Lunch
Chairperson :
Jin-ichi Inokuchi
(Tohoku Pharmaceutical University)
13:30-14:45 ◊  Session 2

Immune responses against glycolipids through C-type lectin receptors
Akira Yamazaki (Kyushu University)

Development of a new pneumococcal vaccine with glycolipid
Yuki Kinjo (NIID)

Immunomodulatory glycoconjugates from microbes: Structure-activity relationships and the application
Yukari Fujimoto (Keio University)
14:45-14:55  Break
Chairperson :
Yuki Kinjo
14:55-16:10 ◊  Session 3

PILR regulate immune response via sugar chain recognition
Hisashi Arase (Osaka University)

Macrohage galactose-type C-type lectin (MGL/CD301) in inflammation and immunity
Kaori Dendao (St. Luke's International Hospital)

The role of CDIR in maintaining immune and bone homeostasis
Yoichiro Iwakura (Tokyo University of Science)
16:10-16:35  Break
  Industry-Academia Joint Seminar
16:35-17:45 Tokyo Chemcal Industry Co.

Approach toward industrialization of glycans until today :GLIT activities and Glycobiologics research meeting
Jun Hirabayashi (AIST)

Addition and remodeling of glycans by use of microbial endoglycosidase
Kenji Yamamoto (Ishikawa Prefectural University)

Technological development of glycan addition by using Endo-M
Toshiyuki Inatu (Tokai University)

Artificial functional glycans and newly development of Neoglycobiologics by use of endoglycosidase
Koji Ito (Tokushima University)
program December 5 (Friday), 2014
9:30-9:40 Introduction by organizer
Naoyuki Taniguchi (RIKEN)
Chairperson :
Naoyuki Taniguchi (RIKEN)
9:40-10:25 Special Lecture I
Treatment for Chronic Obstructive Pulmonary Disease: History, current strategies, and development of personalized medicine
Kozui Kida (Nippon Medical School)
Chairperson :
Koichi Honke (Kochi University)
10:25-10:50 ◊  Session 4

Pathophysiology and treatment of acute exacerbation of chronic obstructive pulmonary disease(COPD)
Tomoko Betsuyaku (Keio University)
10:50-11:20  Break
11:20-12:35 Genetic predictors and biomarkers of COPD exacerbations
Tateo Ishii (Nippon Medical School)

Effect of glycosaminoglycan to cigarette smoke-induced emphysema model mice
Manabu Ueno (Takasaki General Medical Center)

The role of oligosaccharides on the progress of chronic obstructive pulmonary disease
Congxiao Gao (RIKEN)
12:35-14:00  Lunch
Chairperson :
Yasuhiro Kajihara
(Osaka University)
14:00-15:30 ◊  Session 5

Constraction of drug discovery platforms using yeast
Yoko Yashiroda (RIKEN)

Synthesis of bisected N-glycan units and design of glycosyltransferase inhibitors
Shinya Hanashima (Osaka University)

Therapeutic method for malignant tumor using carbohydrate-mimetic peptide
Michiko Fukuda (AIST)
15:30-15:35 Closing Remarks